Who we are
A U.S.-based leader dedicated to researching, cultivating, manufacturing, and delivering next-generation cannabis medicines.
AT A GLANCE
A U.S.-based cultavation , extraction , research and developement BioTech company.
Licensed by OMMA , Oklahoma USA cannabis regulatory Government agency.
Our team of researchers and scientist are working on research exploring cannabis medicines for the treatment of chronic pain and highly addictive precipitation drugs.
Strategically placed to lead a rapidly expanding
market characterized by strong regulatory and operational barriers.
Raising first round
of funding of $40 million to
accelerate expansion and innovation.
OUR FACILITY
A research and development company for integrated cannabis cultivation and pharmaceutical advancement
Heartland Herbal Biotech operates a 150 acres cannabis cultavation farm. Estimated 4th quarter of 2026, our process and extraction facility,4th quarter of 2027 indoor advanced indoor hydroponic cultivation of high-THC cannabis flower, pharmaceutical-grade API extraction systems, and dedicated R&D laboratories gives Heartland Herbal Healing a competitive edge in America's pharmaceutical Cannabis drug development programs.
The facility represents substantial long-term investment and has been established through close collaboration with regulatory authorities to ensure compliance with the highest standards of quality, safety, and operational security.
Development of the facility is planned across three strategic phases:
Phase 1: Completed in 2022, acquiring 150 Acres farm dedicated to
outdoor cannabis cultivation. The average production will be
375,000 pounds per year in dry flower production.
Phase 2: Expansion and Renovation of our 8,000 square feet
for Cannabis Processing and Extraction plant, extimated
completion date December 2026
Phase 3: Further growth of cultivation and manufacturing
capabilities, acquiring 100,000 square feet facility for indoor grow ,
scheduled 4th quarter of 2027,
at full operational capacity, the facility is designed to
produce estimated 92,000 pounds of pharmaceutical cannabis
annually.
OUR MISSION
& VALUES
Driven to advance breakthrough in research with cannabinoid medicines for patients who need them most
